Can molecular dynamics facilitate the design of protein-protein-interaction inhibitors?

CollaPPI: A Collaborative Learning Framework for Predicting Protein-Protein Interactions

Exploring protein-protein interaction (PPI) is of paramount importance for elucidating the intrinsic mechanism of various biological processes. Nevertheless, experimental determination of PPI can be both time-consuming and expensive, motivating the exploration of data-driven deep learning technologies as a viable, efficient, and accurate alternative. Nonetheless, most current deep learning-based methods regarded a pair of proteins to be predicted for possible interaction as two separate entities when extracting PPI features, thus neglecting the knowledge sharing among the collaborative protein and the target protein. Aiming at the above issue, a collaborative learning framework CollaPPI was proposed in this study, where two kinds of collaboration, i.e., protein-level collaboration and task-level collaboration, were incorporated to achieve not only the knowledge-sharing between a pair of proteins, but also the complementation of such shared knowledge between biological domains closely related to PPI (i.e., protein function, and subcellular location). Evaluation results demonstrated that CollaPPI obtained superior performance compared to state-of-the-art methods on two PPI benchmarks. Besides, evaluation results of CollaPPI on the additional PPI type prediction task further proved its excellent generalization ability.

Accelerating therapeutic protein design with computational approaches toward the clinical stage

Therapeutic protein, represented by antibodies, is of increasing interest in human medicine. However, clinical translation of therapeutic protein is still largely hindered by different aspects of developability, including affinity and selectivity, stability and aggregation prevention, solubility and viscosity reduction, and deimmunization. Conventional optimization of the developability with widely used methods, like display technologies and library screening approaches, is a time and cost-intensive endeavor, and the efficiency in finding suitable solutions is still not enough to meet clinical needs. In recent years, the accelerated advancement of computational methodologies has ushered in a transformative era in the field of therapeutic protein design. Owing to their remarkable capabilities in feature extraction and modeling, the integration of cutting-edge computational strategies with conventional techniques presents a promising avenue to accelerate the progression of therapeutic protein design and optimization toward clinical implementation. Here, we compared the differences between therapeutic protein and small molecules in developability and provided an overview of the computational approaches applicable to the design or optimization of therapeutic protein in several developability issues.